drugset / Trial / NCT00845429
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects
RandomizedParallel-groupSingle-blindPrevention
Summary
Primary Objective: To describe the immune response to a single administration of 2 formulations of the investigational cell-based influenza vaccines in healthy adult subjects. Secondary Objective: To describe the safety following a single administration of 2 formulations of the investigational cell-based influenza vaccines in healthy adult subjects.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-08
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza virus vaccine (2007-2008 Formulation) | Vaccine | 0.5 ml | Intramuscular |
| Subject | Influenza virus vaccine - cell based (2007-2008 Formulation) | Vaccine | 0.5 ml | Intramuscular |
| Subject | Influenza virus vaccine - cell based (2007-2008 Formulation) | Vaccine | 1 ml | Intramuscular |